Vivos Therapeutics, Inc.: Form 8-K, filed Sep 8, 2026
Filed with the SEC on Sep 8, 2026 and accepted by EDGAR at Sep 4, 2026, 18:26 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-26-041616. Last ingested by Listed: Nov 2, 2026, 06:07 ET. Listed shows no prices and gives no investment advice.